CC-31244: A Pan-Genotypic Non Nucleoside Inhibitor

CC-31244 is highly potent, selective and active against all genotypes (1-6) with low level cytotoxicity in multiple cell types.

Candidate Status

  • Regulatory filing completed
  • Phase 1 study ongoing
Viral Disease Lead Discovery Lead Optimization Preclinical Regulatory Filing Phase 1
Hepatitis C CC-31244 (NNI)
Lead Discovery Phase complete
Lead Optimization Phase complete
Preclinical Phase complete
Regulatory Filing Phase complete
Phase 1 Phase in progress